Research Article

Related GMR Articles

Hepatocellular carcinoma; MIF-794CATT; Polymorphism; Promoter

Hepatocellular carcinoma (HCC) is one of the most common worldwide malignancies. A relative complete diagnosis system for primary carcinoma of liver has already been established, but the surgical prognosis for HCC, which depends mainly on postoperative pathological classification and data of recurrence and metastasis, lacks valid experimental indicators. Macrophage migration inhibition ... more

T. Yuan; C. Tang; M. Chen; S. Deng; P. Chen
Gene expression; Hepatocellular carcinoma; Laser capture microdissection; Microarray

The aim of this study was to identify genomic aberrations in hepatocellular carcinoma (HCC) by using laser capture microdissection (LCM) combined with microarray analysis. Samples were procured by LCM from HCC and patient-matched normal liver tissue surgically resected from 4 patients. RNA was isolated from the samples and reverse transcribed into cDNA. After 2-cycle linear amplification and 2 ... more

Y.M. Wei; Y.Y. Li; Y.C. Zhang; Y.Q. Nie
Hepatocellular carcinoma; miR-146aG>C rs2910164; miR-499A>G rs3746444; susceptibility

We conducted a case-control study of a possible association of miR-499A>G rs3746444 and miR-146aG>C rs2910164 with risk of hepatocellular carcinoma. Samples from 172 hepatocellular carcinoma patients and 185 cancer-free controls were collected from October 2008 to December 2011. PCR-RFLP analysis was performed to determine the polymorphisms in each individual. The MAFs of miR-146aG ... more

Y.F. Shan; Y.H. Huang; Z.K. Chen; K.T. Huang; M.T. Zhou; H.Q. Shi; Q.T. Song; Z.P. Yu; A.M. Deng; Q.Y. Zhang
Apoptosis; Hepatocellular carcinoma; Methylation regulation; MicroRNA-122

The regulation mechanism and significance of microRNA-122 (miRNA-122) expression are unclear. The aim of this study was to investigate the effects of DNA methylation on liver-specific miRNA-122 expression, cell proliferation, and apoptosis in hepatocellular carcinoma. Methylation of the miRNA-122 promoter region was detected through methylation sequencing. The level of miRNA-122 ... more

T.J. Xing; H.T. Xu; W.Q. Yu; D.F. Jiang
Gene polymorphism; Hepatocellular carcinoma; Interleukin-28B; Liver cirrhosis; Meta-analysis; rs12979860

We examined the association of the interleukin-28B (IL-28B) gene rs12979860 T/C polymorphism with development of hepatitis virus-related hepatocellular carcinoma (HCC) and liver cirrhosis (LC). Two investigators independently searched the PubMed, Elsevier, EMBASE, Web of Science, Wiley Online Library, and Chinese National Knowledge Infrastructure data bases. Pooled odds ratios (ORs) and ... more

G.J. Suo; Z.X. Zhao
Gene polymorphism; Hepatocellular carcinoma; Meta-analysis; XRCC1

XRCC1-399 allele polymorphisms have been reported to be associated with susceptibility to hepatocellular carcinoma (HCC), but the conclusions of the various studies have been inconsistent. We conducted a meta-analysis of available studies to determine whether XRCC1-399 alleles influence susceptibility to hepatocellular carcinoma. We searched English-language databases, ... more

X.Y. Zeng; J.M. Huang; J.W. Xu; Y. Xu; H.P. Yu; L. Ji; X.Q. Qiu
Hepatitis B; Hepatocellular carcinoma; Histocompatibility antigen

Hepatocellular carcinoma is an infection of variable incidence that can be caused by hepatitis B virus (HBV), which is endemic in the Amazon region. The diagnosis of HBV can be performed through the use of serum markers such as the hepatitis B surface antigen. The chronic HBV can cause mutagenesis and carcinogenesis, being the susceptibility of infection due to allele human leukocyte ... more

S.R.S. Chalub; R.M. da Silva; A.P.S. da Silva; P.F. de Aquino; A. Sadahiro; A.N. Kalil
Clinical outcome; Hepatocellular carcinoma; Polymorphism; Vascular endothelial growth factor

We conducted a cohort study to investigate the prognostic significance of vascular endothelial growth factor (VEGF) polymorphisms in hepatocellular carcinoma (HCC) patients after transcatheter arterial chemoembolization (TACE). In total, 156 patients with histologically confirmed HCC within 2 months were collected from January 2007 to January 2008. The genotypes of VEGF-2578C/A ... more

J. Song; L.Z. Wang; X. Li; T.P. Jiang; T.Z. An; M. Xu; X.P. Wu; S. Zhou
Hepatocellular carcinoma; High-intensity focused ultrasound; Nano-hydroxyapatite; Rabbit model

The aims of this study were to evaluate the in vivo safety of intravenous nano-hydroxyapatite (nano-HA), to explore how nano-HA might influence the effects of high-intensity focused ultrasound (HIFU) on normal liver tissue, and to investigate whether intravenous nano-HA could enhance HIFU for hepatocellular carcinoma ablation in a goat model. The present study, for the first ... more

L. Liu; Z. Xiao; Y. Xiao; Z. Wang; F. Li; M. Li; X. Peng
Hepatocellular carcinoma; MMP-9 gene polymorphism; Viral hepatitis

Hepatocellular carcinoma (HCC) is the fifth most common malignancy worldwide. In Egypt, the incidence of HCC has doubled over the last decade. Matrix metalloproteinase-9 (MMP-9) plays a key role in cancer invasion and metastasis by degrading the extracellular matrix and basement membrane barriers. A cytosine (C)/thymidine (T) single nucleotide polymorphism at position -1562 in the MMP-9 ... more

E. Samanoudy; R. Monir; A. Badawy; L. Ibrahim; K. Farag; E. Baz; D. Alenizi; A. Alenezy